Pulmonary sclerosing pneumocytoma: Cytomorphology and immunoprofile.
fine-needle aspiration (FNA)
lung mass or nodule
pulmonary neoplasm
sclerosing hemangioma
sclerosing pneumocytoma
Journal
Cancer cytopathology
ISSN: 1934-6638
Titre abrégé: Cancer Cytopathol
Pays: United States
ID NLM: 101499453
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
21
10
2019
revised:
18
12
2019
accepted:
16
01
2020
pubmed:
6
2
2020
medline:
24
11
2020
entrez:
6
2
2020
Statut:
ppublish
Résumé
Sclerosing pneumocytoma (SP) is a rare, benign pulmonary neoplasm. To the authors' knowledge, the current study is the first to evaluate the cytomorphology and immunoprofile of SP in a series. A total of 9 fine-needle aspiration cases of SP (7 of which were computed tomography guided and 2 of which were endobronchial ultrasound guided) including histopathology and immunohistochemistry were collected from 5 institutions. The female-to-male ratio was 3.5:1, and the mean age of the patients was 54 years (range, 27-73 years). All cases presented as lung nodules, with a mean size of 2.2 cm (range, 1.1-5 cm), and were interpreted as atypical on rapid on-site evaluation. The final diagnoses were favor adenocarcinoma (1 case), well-differentiated lung adenocarcinoma (2 cases), low-grade epithelial neoplasm (2 cases), and sclerosing pneumocytoma (4 cases). Samples were moderately cellular, and consisted of round epithelioid cells with clear cell features, columnar cells, and spindle cells. A papillary arrangement with prominent hyalinized fibrovascular cores was the most common architectural pattern, followed by flat sheets and acinar formations. Tumor cells demonstrated mild, focally moderate nuclear pleomorphism with prominent nucleoli, hyperchromasia, nuclear elongation, nuclear overlap, and occasional nuclear inclusions and grooves. The background consisted of foamy macrophages (9 cases), hemosiderin pigment (6 cases), and lymphoid aggregates (3 cases) with no mitoses and/or necrosis. The surface cells and underlying round cells were positive for both thyroid transcription factor 1 and epithelial membrane antigen in all cases, which was the most notable immunohistochemical finding. Cytomorphological findings of SP overlap with those of well-differentiated lung adenocarcinoma. Awareness of these cytomorphologic findings and the distinct immunoprofile of the 2 cell types found in SP should prevent a misdiagnosis and aggressive treatment.
Sections du résumé
BACKGROUND
Sclerosing pneumocytoma (SP) is a rare, benign pulmonary neoplasm. To the authors' knowledge, the current study is the first to evaluate the cytomorphology and immunoprofile of SP in a series.
METHODS
A total of 9 fine-needle aspiration cases of SP (7 of which were computed tomography guided and 2 of which were endobronchial ultrasound guided) including histopathology and immunohistochemistry were collected from 5 institutions.
RESULTS
The female-to-male ratio was 3.5:1, and the mean age of the patients was 54 years (range, 27-73 years). All cases presented as lung nodules, with a mean size of 2.2 cm (range, 1.1-5 cm), and were interpreted as atypical on rapid on-site evaluation. The final diagnoses were favor adenocarcinoma (1 case), well-differentiated lung adenocarcinoma (2 cases), low-grade epithelial neoplasm (2 cases), and sclerosing pneumocytoma (4 cases). Samples were moderately cellular, and consisted of round epithelioid cells with clear cell features, columnar cells, and spindle cells. A papillary arrangement with prominent hyalinized fibrovascular cores was the most common architectural pattern, followed by flat sheets and acinar formations. Tumor cells demonstrated mild, focally moderate nuclear pleomorphism with prominent nucleoli, hyperchromasia, nuclear elongation, nuclear overlap, and occasional nuclear inclusions and grooves. The background consisted of foamy macrophages (9 cases), hemosiderin pigment (6 cases), and lymphoid aggregates (3 cases) with no mitoses and/or necrosis. The surface cells and underlying round cells were positive for both thyroid transcription factor 1 and epithelial membrane antigen in all cases, which was the most notable immunohistochemical finding.
CONCLUSIONS
Cytomorphological findings of SP overlap with those of well-differentiated lung adenocarcinoma. Awareness of these cytomorphologic findings and the distinct immunoprofile of the 2 cell types found in SP should prevent a misdiagnosis and aggressive treatment.
Identifiants
pubmed: 32022435
doi: 10.1002/cncy.22251
pmc: PMC9261915
mid: NIHMS1786441
doi:
Substances chimiques
Thyroid Nuclear Factor 1
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
414-423Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
© 2020 American Cancer Society.
Références
Ann Diagn Pathol. 2010 Feb;14(1):60-7
pubmed: 20123460
Jpn J Thorac Cardiovasc Surg. 2005 Mar;53(3):157-61
pubmed: 15828298
Ann Thorac Surg. 2004 Dec;78(6):1928-31
pubmed: 15561002
Cell. 2011 Oct 28;147(3):525-38
pubmed: 22036562
Exp Lung Res. 2011 Aug;37(6):344-53
pubmed: 21649526
Cancer. 1956 Jan-Feb;9(1):53-75
pubmed: 13284701
Diagn Cytopathol. 2002 Mar;26(3):163-6
pubmed: 11892021
Virchows Arch. 2007 Feb;450(2):221-3
pubmed: 17120028
J Bronchology Interv Pulmonol. 2009 Jul;16(3):188-90
pubmed: 23168550
Virchows Arch A Pathol Anat Histopathol. 1985;407(4):419-30
pubmed: 2413615
Arch Pathol Lab Med. 2003 Mar;127(3):321-5
pubmed: 12653576
J Korean Med Sci. 2004 Jun;19(3):352-8
pubmed: 15201499
Acta Cytol. 1994 Jan-Feb;38(1):111-2
pubmed: 8291347
World J Surg Oncol. 2013 Apr 15;11:85
pubmed: 23587094
Am J Surg Pathol. 1986 Jun;10(6):429-35
pubmed: 3717498
Medicine (Baltimore). 2015 Jan;94(4):e498
pubmed: 25634202
Diagn Cytopathol. 2014 Jan;42(1):5-10
pubmed: 23637102
Acta Cytol. 1986 Jan-Feb;30(1):51-4
pubmed: 3004083
Acta Cytol. 2016;60(1):85-8
pubmed: 26934286
Diagn Cytopathol. 2001 Nov;25(5):316-20
pubmed: 11747223
Medicina (Kaunas). 2019 Jan 25;55(2):
pubmed: 30691016
Pathol Int. 2018 Mar;68(3):196-201
pubmed: 29451344
Nature. 2015 Jan 29;517(7536):616-20
pubmed: 25383540
Diagn Cytopathol. 1993;9(3):304-9
pubmed: 8519196
Medicine (Baltimore). 2019 Apr;98(15):e15038
pubmed: 30985653
Cytojournal. 2016 Apr 20;13:9
pubmed: 27168758
Yonsei Med J. 2003 Feb;44(1):150-4
pubmed: 12619190
Acta Cytol. 1993 Nov-Dec;37(6):933-7
pubmed: 8249516
Clin Respir J. 2014 Apr;8(2):133-6
pubmed: 23910931
Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):407-14
pubmed: 18091383
Diagn Cytopathol. 2017 Aug;45(8):744-749
pubmed: 28398699
Arch Pathol Lab Med. 2009 May;133(5):820-5
pubmed: 19415961
Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):89-91
pubmed: 24739840
Am J Surg Pathol. 1980 Aug;4(4):343-56
pubmed: 6252791
Diagn Cytopathol. 2014 Mar;42(3):242-6
pubmed: 22645055
Am J Surg Pathol. 2000 Jul;24(7):906-16
pubmed: 10895813
Gen Thorac Cardiovasc Surg. 2009 Dec;57(12):667-70
pubmed: 20013104
Cytopathology. 1995 Apr;6(2):126-7
pubmed: 7795162
Am J Surg Pathol. 2007 Oct;31(10):1512-20
pubmed: 17895751
Sci Rep. 2014 Aug 18;4:6102
pubmed: 25130377